Compare · BWXT vs TMO
BWXT vs TMO
Side-by-side comparison of BWX Technologies Inc. (BWXT) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BWXT and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $175.70B, about 10.3x BWXT ($17.04B).
- Over the past year, BWXT is up 40.1% and TMO is up 15.7% - BWXT leads by 24.4 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 2 for BWXT).
- TMO has more recent analyst coverage (25 ratings vs 23 for BWXT).
- Company
- BWX Technologies Inc.
- Thermo Fisher Scientific Inc
- Price
- $185.72-2.60%
- $472.71-1.94%
- Market cap
- $17.04B
- $175.70B
- 1M return
- -13.68%
- -0.15%
- 1Y return
- +40.07%
- +15.69%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 2
- 17
- Recent ratings
- 23
- 25
BWX Technologies Inc.
BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. Its Nuclear Operations Group segment offers nuclear components, reactors, assemblies, and fuel for the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program and other uses; close-tolerance equipment for nuclear applications; research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. It also provides missile launch tubes for the United States Navy submarines; converts Cold War-era government stockpiles of high-enriched uranium; and receives, stores, characterizes, dissolves, recovers, and purifies uranium-bearing materials. Its Nuclear Services Group segment provides nuclear materials processing, environmental site restoration, and management and operating services for the United States government-owned facilities; develops technology for advanced nuclear power sources application; designs, engineers, licenses, and manufactures advance nuclear reactors; and inspects and services steam generators, heat exchangers, reactors, fuel handling systems, and balance of plants; and provides non-destructive examination and tooling/repair solutions, and nuclear fuel. Its Nuclear Power Group segment offers commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and containers; nuclear fuel, fuel handling systems, tooling delivery systems, and related services, as well as engineering and in-plant services for nuclear power plants; and medical radioisotopes and radiopharmaceuticals. It also designs, manufactures, commissions, and services nuclear power generation equipment. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. The company was founded in 1867 and is headquartered in Lynchburg, Virginia.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BWXT
- BWXT Manufactures TRISO Fuel Enabling First New Reactor Criticality Under DOE Program
- SEC Form SD filed by BWX Technologies Inc.
- BWX Technologies upgraded by Deutsche Bank with a new price target
- The Hypersonic Test Bottleneck Is Real — And Five Companies Are Building the Infrastructure to Fix It
- The Other Side of the Nuclear Renaissance: How Domestic Uranium Lands on the Pre-Feasibility Calendar
- President and CEO Geveden Rex D sold $2,048,124 worth of shares (10,000 units at $204.81) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 202,491 units (SEC Form 4)
- SVP & Chief Financial Officer Fitzgerald Michael Thomas exercised 2,417 shares at a strike of $102.99 and sold $505,757 worth of shares (2,417 units at $209.25) (SEC Form 4)
- SEC Form 144 filed by BWX Technologies Inc.
- SVP & Chief Financial Officer Fitzgerald Michael Thomas exercised 2,826 shares at a strike of $61.70 and covered exercise/tax liability with 1,618 shares, increasing direct ownership by 21% to 6,884 units (SEC Form 4)
- Before the Drill Rigs Arrive at America's Largest Conventional Uranium Deposit, the Permitting Work Is Already Moving -- and Eagle Nuclear Just Made That Operationally Public
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)